Literature DB >> 15784918

Clinician-parent communication during informed consent for pediatric leukemia trials.

Victoria A Miller1, Dennis Drotar, Christopher Burant, Eric Kodish.   

Abstract

OBJECTIVE: To address the need to describe informed consent in pediatric settings and to identify barriers to parent understanding, this study assessed how aspects of clinician-parent communication during the informed consent conference (ICC) relate to parent understanding of informed consent and parent perception of the impact of the ICC on their anxiety and control.
METHODS: Parents of 127 children with newly diagnosed leukemia who were eligible for clinical trials were the participants. The study used comprehensive methods including both observational and self-report assessment methods.
RESULTS: Structural equation modeling demonstrated that parent race and socioeconomic status (SES) were powerful predictors of clinician-parent communication, parent anxiety and control as a result of the ICC, and parent understanding. Clinician information giving and partnership building predicted parent participation during the ICC.
CONCLUSIONS: These findings may be used to design interventions that increase the effectiveness of the ICC by identifying specific elements of the conference that influence parent affect and understanding.

Entities:  

Mesh:

Year:  2005        PMID: 15784918     DOI: 10.1093/jpepsy/jsi032

Source DB:  PubMed          Journal:  J Pediatr Psychol        ISSN: 0146-8693


  18 in total

1.  Parent participation and physician-parent communication during informed consent in child leukemia.

Authors:  Melissa Cousino; Rebecca Hazen; Amy Yamokoski; Victoria Miller; Stephen Zyzanski; Dennis Drotar; Eric Kodish
Journal:  Pediatrics       Date:  2011-11-07       Impact factor: 7.124

2.  Participation in pediatric oncology research protocols: Racial/ethnic, language and age-based disparities.

Authors:  Paula Aristizabal; Jenelle Singer; Renee Cooper; Kristen J Wells; Jesse Nodora; Mehrzad Milburn; Sheila Gahagan; Deborah E Schiff; Maria E Martinez
Journal:  Pediatr Blood Cancer       Date:  2015-03-08       Impact factor: 3.167

3.  Bioethics In Practice: Understanding Understood Consent.

Authors:  Robert J Vasquez
Journal:  Ochsner J       Date:  2017

4.  Educating Parents About Pediatric Research: Children and Clinical Studies Website Qualitative Evaluation.

Authors:  Lisa D Marceau; Lisa C Welch; Victoria L Pemberton; Gail D Pearson
Journal:  Qual Health Res       Date:  2015-12-28

5.  Caregivers' Understanding of Informed Consent in a Randomized Control Trial.

Authors:  Dorothy Helen Boyd; Yinan Zhang; Lee Smith; Lee Adam; L Foster Page; W M Thomson
Journal:  J Bioeth Inq       Date:  2021-01-15       Impact factor: 1.352

Review 6.  Recommendations for enhancing clinical trials education: a review of the literature.

Authors:  Karen A Stepan; Amy P Gonzalez; Vivian S Dorsey; Debra K Frye; Nita D Pyle; Regina F Smith; Terry A Throckmorton; Louise A Villejo; Scott B Cantor
Journal:  J Cancer Educ       Date:  2011-03       Impact factor: 2.037

7.  Factors related to voluntary parental decision-making in pediatric oncology.

Authors:  Victoria A Miller; Robert M Nelson
Journal:  Pediatrics       Date:  2012-04-16       Impact factor: 7.124

8.  Advancing the field of communication research in pediatric oncology: A systematic review of the literature analyzing medical dialogue.

Authors:  Erica C Kaye; Ashley Kiefer; Kristina Zalud; Melanie Gattas; Ian Snyder; Holly Spraker-Perlman; Justin N Baker
Journal:  Pediatr Blood Cancer       Date:  2018-08-01       Impact factor: 3.167

9.  A feasibility trial of a video intervention to improve informed consent for parents of children with leukemia.

Authors:  Rebecca A Hazen; Michelle Eder; Dennis Drotar; Steve Zyzanski; Amy E Reynolds; C Patrick Reynolds; Eric Kodish; Robert B Noll
Journal:  Pediatr Blood Cancer       Date:  2010-07-15       Impact factor: 3.167

10.  Ethical issues in health research in children.

Authors: 
Journal:  Paediatr Child Health       Date:  2008-10       Impact factor: 2.253

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.